{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_19264", "batch_size": 200, "batch_pos": 145, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain a high-potency verb, potent metaphor, critical alert phrase, superlative + negative noun, or intensifier + harm noun.", "method": "llm_batch", "batch_id": "batch_2_21128", "batch_size": 200, "batch_pos": 117, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "Segment does not contain a moderate verb paired with explicit scale or impact.", "method": "llm_batch", "batch_id": "batch_3_11768", "batch_size": 200, "batch_pos": 90, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_19088", "batch_size": 200, "batch_pos": 87, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "Reports discussions; no explicit calming cue.", "method": "llm_batch", "batch_id": "batch_5_17432", "batch_size": 200, "batch_pos": 85, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "No 'minimiser + scale contrast' pattern found.", "method": "llm_batch", "batch_id": "batch_6_17028", "batch_size": 200, "batch_pos": 52, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment confirms discussions, containing no bare negation.", "method": "llm_batch", "batch_id": "batch_7_8916", "batch_size": 200, "batch_pos": 47, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "Describes ongoing work on developing a vaccine candidate (capability) ('in discussions... on advancing our pandemic flu candidate') without explicit calming.", "method": "llm_batch", "batch_id": "batch_8_14488", "batch_size": 200, "batch_pos": 131, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
